2010 Flashcards
Obstructive renal failure with hyperkalemia (no level given).
a) give 4 EKG changes
b) list 4 management principles
a) i. Peaked T waves
ii. Widened QRS
iii. Bradycardia
iv. Sinus wave pattern
- prolonged PR
- decreased or disappearing P wave
b)
i. Stabilization of cardiac membrane with calcium
ii. Shift of K into cells – alkalinization (bicarb), beta agonism (ventolin), insulin & glucose
iii. Excretion via binder? – kayexalate
iv. Hemodialysis
What mode of ventilation is shown in the illustration?
a) Give three contraindications to its use.
b) proposed advantages
Contraindication:
i. COPD b/c of risk of hyperinflation
ii. Upper airway obstruction
iii. Problems with increased ICP
iv. Neuromuscular disease
Proposed advantages:
i. Lower peak airway pressures
ii. Lower minute ventilation
iii. Decreased adverse effects upon circulatory function
iv. Spontaneous ventilation throughout entire I/E cycle
v. Decreased need for sedation??
vi. Near elimination of NMB
Proposed disadvantages
i. Barotrauma
ii. Volutrauma, atelectrauma
Compare CSW & SIADH based on:
CVP, IV volume, urine osm, urine Na, serum Na
see image
- Post-op bowel resection starting TPN – what nutrient do you not give?
PARENTERAL nutrition recommendations on supplements:
- glutamine should not be used
- parenteral dipeptides should not be used
- insufficient data for zinc
- IV lipids that reduce amount of omega 6 fatty acids
- insufficient data RE: IV branched chain amino acids
2015 Recommendation: Based on 31 studies (10 level 1 studies and 21 level 2 studies), when parenteral nutrition is prescribed to critically ill patients, we recommend parenteral supplementation with glutamine NOT be used. There are insufficient data on the use of intravenous glutamine in critically ill patients receiving enteral nutrition but given the safety concerns we also recommend intravenous glutamine not be used in enterally fed critically ill patients.
2015 Recommendation: There are insufficient data to make a recommendation on the use of enteral glutamine vs. parenteral dipeptide supplementation. However given concerns of glutamine supplementation in general as per sections 4.1c EN glutamine, 9.4a PN glutamine and 9.4b EN+PN glutamine, we strongly recommend that glutamine supplementation NOT be used in critically ill patients, hence we do not recommend the use of enteral glutamine or parenteral dipeptides.
Recommendation: There are insufficient data to make a recommendation regarding IV/PN zinc supplementation in critically ill patients.
2015 Recommendation: When parenteral nutrition with intravenous lipids is indicated, IV lipids that reduce the load of omega-6 fatty acids/soybean oil emulsions should be considered. However, there are insufficient data to make a recommendation on the type of lipids to be used that reduce the omega-6 fatty acid/soybean oil load in critically ill patients receiving parenteral nutrition.
2013 Recommendation: In patients receiving parenteral nutrition or enteral nutrition, there are insufficient data to make a recommendation regarding the use of intravenous supplementation with higher amounts of branched chain amino acids in critically ill patients.
HFOV:
contraindications (2)
complications (2)
how to improve oxygenation (other than O2)
give two causes of chest wiggling?
2 contraindications
i. Known severe airflow obstruction
ii. Severe intracranial hypertension
2 complications
i. Pneumothorax
ii. Hypotension
How to improve oxygenation
i. Increase mPaw by 2 cm water increments
ii. Recruitment maneuver
iii. Increase bias gas flow
2 possible causes for the left chest to stop wiggling
i. Right mainstem intubation
ii. Pneumothorax
iii. Mucous plugging and atelectasis
Pressure time curve
a. Label where pressure overcomes airway resistance.
b. Label where pressure overcomes respiratory system elastance.
I’m not sure…
a. ? when flow starts during inspiration the ventilator must have overcome the resistance
b. ?no idea what this means…
Regarding transpulmonary pressue. How do you calculate it?
a) i. Transpulmonary pressure = plateau pressure (alveolar P) – pleural pressure
ii. plateau pressure (alveolar pressure) measured by inspiratory hold
iii. Intrapleural pressure measured by esophageal balloon
how did ARDSnet calculate weight for tidal volume?
what blood gas value did ARDSnet target to be normal?
b) i. Predicted body weight based on height
ii. PBW Male = 50 + 2.3 (height in inches -60)
iii. PBW Female = 45.5 + 2.3 (height inches - 60)
i. PaO2 of 55-80 mm Hg or Sat 88-95%
What are two risk factors for development of non-traumatic pneumothorax in a
ventilated patient?
Alveolar overdistention: (Bagging, RM intubation, excess MAP/PEEP)
Primary disease:
- Obstructive lung disease, asthma
- ARDS/ALI
- necrotizing lung infection
- lung malignancy
- 4 steps for assessing a qualitative cuff leak.
- supraglottic suction
- ?preoxygenate
- deflate cuff
- feel and listen for air movement using stethoscope on pts trachea
Auscultation – deflate the cuff & occlude the ETT, put your hand at mouth to feel exhaled air
Record the difference between the inspiratory tidal volume & the expiratory tidal volume while the cuff around the ETT is deflated (average of any 3 values on 6 consecutive breaths).
- Cuff leak < 110 ml is more associated with post-extubation stridor.
c. Record the difference in exhaled tidal volume from before to after ETT cuff deflation. Divide this number by the exhaled tidal volume before cuff deflation. This is “percent cuff leak”. - Patients with a cuff leak of < 10% are at risk for stridor or reintubation.
e. Qualitative
i. Deflate cuff
ii. Occlude ETT
iii. Feel for air
iv. Listen for air
Name the two most important abnormalities on the flow volume loop (patient is obese & has a history of pneumonia, prolonged wean & trach).
Name 2 abnormalties. What is the most likely diagnosis?
I guessed at the loops based on the previously provided description…
see image with associated captions
Myotonic dystrophy with influenza CAP, now going to the ward. Intubated & extubated a few times. Trouble swallowing. Symptoms of cor pulmonale for 6 months prior to admission. What 4 long-term interventions will reduce readmissions to the ICU?
a. Physio
b. Secretion management
c. Trach for pulmonary toilet
d. Code discussion
e. Feeding tube & nutrition
f. Assessment for need for nocturnal biPAP
g. Vaccination with Pneumovax
I couldn’t confirm above…but found one paper suggesting:
?avoiding discharges between 6pm and 6am?
When should antibitotics be administered in the setting of severe septic shock? What is one indication for dual antibiotic coverage?
a. Within one hour of diagnosis (and preferably after blood cultures drawn)
b. Dual antibiotic coverage for neutropenic patients or those with documented or high suspicion of pseudomonas infection.
From Surviving Sepsis Campaign guidelines:
Multidrug therapy is often required to ensure a sufficiently broad spectrum of empiric coverage initially. Clinicians should be cognizant of the risk of resistance to broad-spectrum β-lactams and carbapenems among gram-negative bacilli in some communities and healthcare settings. The addition of a supplemental gram-negative agent to the empiric regimen is recommended for critically ill septic patients at high risk of infection with such multidrug-resistant pathogens (e.g., Pseudomonas, Acinetobacter, etc.) to increase the probability of at least one active agent being administered (110). Similarly, in situations of a more-than-trivial risk for other resistant or atypical pathogens, the addition of a pathogen-specific agent to broaden coverage is warranted. Vancomycin, teicoplanin, or another anti-MRSA agent can be used when risk factors for MRSA exist. A significant risk of infection with Legionella species mandates the addition of a macrolide or fluoroquinolone.
- Meningococcal meningitis on antibiotics. 3 days out with no sedation but GCS of 5.
a. What are 2 potential causes for a reduced LOC?
b. Most appropriate test?
- Cerebral edema or raised ICP
- Seizures
- thrombosis, vasculitis, acute cerebral hemorrhage, mycotic aneurysms
- ischemic infarct
- Hydrocephalus – but CT head normal
- Cerebral venous thrombosis (usually sagittal sinus thrombosis)
b) MRA/MRV vs EEG???
Forest plot.
a. Is there statistical hererogeneity?
b. What are 2 potential causes for statistical heterogeneity?
- Visually assess the Forest plot
a. If confidence intervals of two studies do not overlap you can
assume they have a high degree of heterogeneity
b. First graph = heterogeneity
c. Second = lack of statistical heterogeneity
do statistical test (chi square)???
i. Small sample size
ii. Publication bias
The heterogeneity is indicated by the I2. A heterogeneity of less than 50% is termed low, and indicates a greater degree of similarity between study data than an I2 value above 50%, which indicates more dissimilarity.
Severe hypothyroidism with bradycardia, hypotension & pneumonia. What 3 treatments would you give aside from ventilation & fluids?
- T4 IV in loading dose of 200 to 400 mcg following by 50-100mcg daily
- T3 may be given simultaneously 5 to 20 mcg IV then 2.5-10mcg q8H
- Hydrocortisone 100 mg IV q8H because of possible coexisting adrenal insufficiency
- Antibiotics & supportive care
- Passive NOT active rewarming